Renee D Gala is President & COO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 55,492 shares of JAZZ, which is worth approximately $6.91 Million. The most recent transaction as insider was on Dec 05, 2024, when has been sold 80 shares (Ordinary Shares) at a price of $123.45 per share, resulting in proceeds of $9,876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.5K
0.24% 3M change
50.44% 12M change
Total Value Held $6.91 Million

RENEE D GALA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 05 2024
SELL
Payment of exercise price or tax liability
$9,876 $123.45 p/Share
80 Reduced 0.14%
55,492 Ordinary Shares
Apr 05 2024
SELL
Payment of exercise price or tax liability
$200,004 $115.21 p/Share
1,736 Reduced 3.04%
55,357 Ordinary Shares
Mar 05 2024
SELL
Payment of exercise price or tax liability
$425,693 $117.53 p/Share
3,622 Reduced 5.97%
57,093 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
19,916 Added 24.7%
60,715 Ordinary Shares
Jan 17 2024
SELL
Payment of exercise price or tax liability
$381,692 $119.13 p/Share
3,204 Reduced 7.28%
40,799 Ordinary Shares
Jan 17 2024
BUY
Grant, award, or other acquisition
-
7,079 Added 13.86%
44,003 Ordinary Shares
Nov 10 2023
BUY
Grant, award, or other acquisition
-
772 Added 2.05%
36,887 Ordinary Shares
May 18 2023
SELL
Open market or private sale
$790,500 $131.75 p/Share
6,000 Reduced 14.29%
35,978 Ordinary Shares
Apr 05 2023
SELL
Payment of exercise price or tax liability
$263,424 $145.78 p/Share
1,807 Reduced 4.13%
41,978 Ordinary Shares
Mar 05 2023
SELL
Payment of exercise price or tax liability
$222,308 $142.78 p/Share
1,557 Reduced 3.43%
43,785 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
-
12,784 Added 21.99%
45,342 Ordinary Shares
Dec 21 2022
SELL
Open market or private sale
$421,600 $160.0 p/Share
2,635 Reduced 7.49%
32,558 Ordinary Shares
Apr 05 2022
SELL
Payment of exercise price or tax liability
$265,983 $162.88 p/Share
1,633 Reduced 4.46%
34,995 Ordinary Shares
Mar 05 2022
SELL
Sale (or disposition) back to the issuer
$110,851 $153.96 p/Share
720 Reduced 1.93%
36,628 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
11,730 Added 23.9%
37,348 Ordinary Shares
Apr 05 2021
SELL
Payment of exercise price or tax liability
$249,536 $164.71 p/Share
1,515 Reduced 5.64%
25,347 Ordinary Shares
Feb 25 2021
BUY
Grant, award, or other acquisition
-
10,115 Added 27.35%
26,862 Ordinary Shares

Also insider at

GOSS
Gossamer Bio, Inc. Healthcare
RDG

Renee D Gala

President & COO
San Diego, CA

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ